The use of genotyping to predict the phenotypes of human platelet antigens 1 through 5 and of neutrophil antigens in Taiwan.
BACKGROUND
The human platelet antigen (HPA) 1 through 5 and the human neutrophil antigen (HNA-1) systems are relevant to immune-related thrombocytopenia and neutropenia. The alloantigen distribution profiles in the population will aid in estimating the risk of alloimmunization.


METHODS
Genotyping of the genes that control the expression of the HPA-1 through -5 and HNA-1 systems in Taiwanese (n = 326) and Taiwan's indigenous peoples (n = 608) was performed by PCR with the sequence-specific primer (PCR-SSP) method.


RESULTS
In the HPA system, HPA-1b and HPA-4b were absent among Taiwan's indigenous tribes and detected among other Taiwanese only with frequencies of <0.2 percent and <0.5 percent, respectively. The GP1BA*2 (HPA-2b) and GP1A*2 (HPA-5b) allele frequencies range from 1 percent to 7 percent and 0.4 percent to 3.5 percent among the two ethnic groups, respectively. GP2B*1 (HPA-3a) and GP2B*2 (HPA-3b) showed similar allele frequencies. In the HNA-1 system, the FCGR3B*1 (HNA-1a) allele frequency was about twice that of FCGR3B*2 (HNA-1b) in Taiwanese and also in most of the indigenous tribes. Three FCGR3B (HNA-1) null persons were found in one indigenous tribe (Ami tribe), for an FCGR3B null frequency of 19.8 percent. However, no FCGR3B*3 (HNA-1c) allele was detected in Taiwan.


CONCLUSIONS
The frequencies of HPA-1b, -2b, and -5b in the Taiwanese population were much lower than those among whites. In Taiwan, all of the HNA-1 null found was due to the deletion of the FCGR3B gene, and this deletion may be widely distributed in the Ami tribe.
Chu
C C
CC
Transfusion Medicine Research Laboratory and the Immunohematology Reference Laboratory, Mackay Memorial Hospital, Taipei, Taiwan.
Lee
H L
HL
Chu
T W
TW
Lin
M
M
D016824:Antigens, Human Platelet / Q000235:genetics*; D005006:Ethnicity / Q000235:genetics; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D039661:Integrin beta3; D008403:Mass Screening; D010641:Phenotype; D016133:Polymerase Chain Reaction; D013624:Taiwan / Q000453:epidemiology; D023084:alpha-Defensins / Q000172:deficiency / Q000235:genetics*
C115212:2a alloantigen, human; C071221:2b alloantigen, human; C044561:3a alloantigen, human; C083448:3b alloantigen, human; C057260:4a alloantigen, human; C510800:4b alloantigen, human; C071092:5a alloantigen, human; C055973:5b alloantigen, human; D016824:Antigens, Human Platelet; C061248:ITGB3 protein, human; D039661:Integrin beta3; D023084:alpha-Defensins; C406413:human neutrophil peptide 1; C083451:human platelet antigen 1b